Marina Urena

Showing 1-15 of 15 articles

Interventions for valvular disease

Predictors and clinical impact of thrombosis after transcatheter mitral valve implantation using balloon-expandable bioprostheses

Kikoïne J, Urena M, Chong Nguyen C, Fischer Q, Carrasco J, Brochet E, Ducrocq G, Vahanian A, Iung B, Himbert D

April 20, 2021 | 10.4244/EIJ-D-20-00991

Incorporating patients’ preferences into the Heart Team equation

Vahanian A, Urena M

November 20, 2020 | 10.4244/EIJV16I10A146

Patient selection for transcatheter mitral valve implantation: why is it so hard to find patients?

Urena M, Vahanian A, Søndergaard L

September 7, 2018 | 10.4244/EIJ-D-18-00510

Interventions for valvular disease

Alcohol septal ablation preceding transcatheter valve implantation to prevent left ventricular outflow tract obstruction

Sayah N, Urena M, Brochet E, Himbert D

April 20, 2018 | 10.4244/EIJ-D-17-00742

Interventions for valvular disease

Management of radiation-induced valvular heart disease due to Hodgkin’s Lymphoma in the modern era

Paven E, Cimadevilla C, Urena M, Dilly M-P, Nataf P, Raffoul R, Himbert D, Vahanian A, Messika-Zeitoun D

February 2, 2018 | 10.4244/EIJ-D-17-00811

Interventions for valvular disease

Mitral valve: repair/clips/cinching/chordae

Vahanian A, Urena M, Ince H, Nickenig G

September 24, 2017 | 10.4244/EIJ-D-17-00505

Interventions for valvular disease

Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial

Urena M, Del Trigo M, Altisent O, Campelo-Parada F, Regueiro A, Delarochelliere R, Doyle D, Mohammadi S, Paradis J, Dagenais F, Dumont E, Puri R, Laroche V, Rodés-Cabau J

May 15, 2017 | 10.4244/EIJ-D-16-00591

Interventions for valvular disease

Suprasternal brachiocephalic approach as an alternative route for transcatheter aortic valve implantation: a single-centre experience

Capretti G, Urena M, Himbert D, Ghodbane W, Verdonck P, Goublaire c, Alkhoder S, Raffoul R, Carrasco J, Laredo M, Nataf P, Vahanian A

February 3, 2017 | 10.4244/EIJ-D-16-00353

Coronary interventions

Safety and effectiveness of the surfing technique to cross septal collateral channels during retrograde chronic total occlusion percutaneous coronary intervention

Dautov R, Urena M, Nguyen C, Gibrat C, Rinfret S

February 3, 2017 | 10.4244/EIJ-D-16-00650

Interventions for valvular disease

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial

Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence M, Redwood S, Kahlert P, Rodés-Cabau J, Leipsic J, Webb J

June 10, 2016 | 10.4244/EIJV12I2A37

Interventions for valvular disease

Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications

Urena M, Rodés-Cabau J

September 17, 2015 | 10.4244/EIJV11SWA30

Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance

Ribeiro H, Larose E, de la Paz Ricapito M, Le Ven F, Nombela-Franco L, Urena M, Allende R, Amat-Santos I, Dahou A, Capoulade R, Clavel M-A, Mohammadi S, Paradis J, De Larochelliere R, Doyle D, Dumont E, Pibarot P, Rodés-Cabau J

June 19, 2015 | 10.4244/EIJV11I2A39

Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device

Amat-Santos I, Bergeron S, Bernier M, Allende R, Ribeiro H, Urena M, Pibarot P, Verheye S, Keren G, Yaacoby M, Nitzan Y, Abraham W, Rodés-Cabau J

January 22, 2015 | 10.4244/EIJY14M05_07

Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve

Nombela-Franco L, Ribeiro H, Urena M, Pasian S, Allende R, Doyle D, Delarochelliere R, DeLarochelliere H, Laflamme L, Laflamme J, Jerez-Valero M, Cote M, Pibarot P, Larose E, Dumont E, Rodés-Cabau J

April 22, 2014 | 10.4244/EIJV9I12A237

Edwards CENTERA valve

Ribeiro H, Urena M, Kuck K, Webb J, Rodés-Cabau J

September 30, 2012 | 10.4244/EIJV8SQA14

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease